Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001641172-25-010252
Filing Date
2025-05-14
Accepted
2025-05-14 16:01:40
Documents
61
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q form10-q.htm   iXBRL 10-Q 1062005
2 EX-31.1 ex31-1.htm EX-31.1 15260
3 EX-31.2 ex31-2.htm EX-31.2 15305
4 EX-32.1 ex32-1.htm EX-32.1 5859
  Complete submission text file 0001641172-25-010252.txt   5134731

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE fblg-20250331.xsd EX-101.SCH 39974
6 XBRL CALCULATION FILE fblg-20250331_cal.xml EX-101.CAL 46854
7 XBRL DEFINITION FILE fblg-20250331_def.xml EX-101.DEF 175650
8 XBRL LABEL FILE fblg-20250331_lab.xml EX-101.LAB 363892
9 XBRL PRESENTATION FILE fblg-20250331_pre.xml EX-101.PRE 287315
63 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 669143
Mailing Address 455 E. MEDICAL CENTER BLVD SUITE 300 SUITE 300 HOUSTON TX 77598
Business Address 455 E. MEDICAL CENTER BLVD SUITE 300 HOUSTON TX 77598 281-671-5150
FibroBiologics, Inc. (Filer) CIK: 0001958777 (see all company filings)

EIN.: 863329066 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41934 | Film No.: 25945128
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)